Down 2.3% to $26.84, Abaxis (NASDAQ:ABAX), is one of today's notable movers. The Dow is down 0.6% to 12,581 and the S&P is currently down 0.7% to 1,308.
Abaxis has overhead space with shares priced $26.84, or 16.2% below the average consensus analyst price target of $32.03. The stock should hit resistance at its 50-day moving average (MA) of $27.49, as well as support at its 200-day MA of $26.79.
Abaxis, Inc. develops, manufactures, and markets portable blood analysis systems for use in any patient care setting. The Company's systems provide clinicians with rapid blood constituent measurements. Abaxis currently markets the VetScan for veterinary use and the Piccolo for human medical use. The Company's products are sold in the United States, as well as in Europe and Japan.
Over the past year, Abaxis has traded in a range of $19.68 to $31.69 and is now at $26.84, 36% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.5% while the 200-day MA has remained constant.
